Send feedback

APC p.Ser634Arg

c.1902T>G · rs876659460 · VCV231954

Uncertain significance Expert panel
Classification
Uncertain significance
ClinVar
Review
Expert panel ★★★☆
ClinVar · 5 submitters
AlphaMissense
likely pathogenic
0.9995 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000186%)
Conditions
2
familial adenomatous polyposis 1

ClinGen expert panel — InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP

Uncertain Significance for familial adenomatous polyposis 1. Applied ACMG criteria (verbatim):

PM2_Supporting BP1

Curation rationale (ClinGen, verbatim)

The NM_000038.6(APC):c.1902T>G (p.Ser634Arg) variant in APC is a missense variant predicted to cause substitution of Serine by Arginine at amino acid position 634 (p.Ser634Arg). This variant has been reported in 1 proband meeting phenotypic criteria, resulting in a total phenotype score of 0.5 (PS4 not met [Ambry]). The variant has been reported in 1 additional proband with a colorectal cancer/polyposis associated phenotype not meeting phenotypic criteria (PMID: 27696107). The total minor allele frequency in gnomAD v2.1.1 (non-cancer) is 0.0004% (1/236788 alleles), which is lower than the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis VCEP (HCCP VCEP) threshold < 0.001% (0.00001) for PM2_Supporting if the allele count is ≤ 1 and therefore meets this criterion (PM2_Supporting). RT-PCR of cDNA and mini-gene splicing assays demonstrated that the variant impacts splicing by skipping of exon 15 resulting in a premature stop codon (PMID: 24599579). However, since alternative splicing/skipping of this exon is known and in PMID: 24599579 no pronounced skipping compared to controls is described, PS3 is not applicable. Moreover, the results from ≥ 2 in silico splicing predictors (SpliceAI and MaxEntScan) support that this variant does not affect splicing. APC, in which the variant was identified, is defined by the HCCP VCEP as a gene for which primarily truncating variants are known to cause disease (BP1). Due to conflicting evidence, this variant is a variant of uncertain significance (VUS) for autosomal-dominant inherited FAP based on the ACMG/AMP criteria applied, as specified by the HCCP VCEP: PM2_Supporting, BP1 (VCEP specifications version v2.0.3; date of approval 7/24/2023).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.9995likely pathogenic · top 1% in APC
REVEL0.452indeterminate
SaProt—not scored · why
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.66GERP -1.9, phastCons 1
Regional constrainto/e 0.74unconstrained · MANE · 11 kb · p 4.8e-05 · regional, not allelic
Overall
CADD23.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000186%
Overall 0.000186% 3/1,614,076 alleles · very rare exomes 3/1,461,840 · genomes 0/152,236 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
APC
Protein
p.Ser634Arg
Coding
c.1902T>G
MANE Select
NM_000038
dbSNP
rs876659460
Type
single nucleotide variant
Location
chr5:112835109 (GRCh38)
Gene constraint
LOEUF 0.321 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Residue 634
an α-helix
Full APC gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

familial adenomatous polyposis 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary neoplastic syndrome

For Familial adenomatous polyposis (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive
Onset
Adult
Prevalence
1-9 / 100 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/apc-p-ser634arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown